• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚合物两亲性纳米粒作为口服药物载体的生物相容性、细胞摄取和体内分布。

Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers.

机构信息

College of Marine Life Science, Ocean University of China, Qingdao 266003, PR China.

出版信息

Colloids Surf B Biointerfaces. 2013 Mar 1;103:345-53. doi: 10.1016/j.colsurfb.2012.11.012. Epub 2012 Nov 29.

DOI:10.1016/j.colsurfb.2012.11.012
PMID:23247264
Abstract

Oleoyl-carboxymethyl-chitosan (OCMCS) was synthesized and were soluble at neutral pH. The critical micelle concentration (CMC) of OCMCS in deionized water was 0.021 mg/ml. OCMCS nanoparticles were successfully prepared via self-assembly with mean diameter of 215.34 nm, zeta potential of 19.26 mV and an almost spherical shape as determined by electron microscopy. The OCMCS nanoparticles showed low erythrocyte membrane-damaging effect. The MTT survival assay indicated no significant cytotoxicity to Caco-2 cells and MEFs cells. The uptake of FITC labeled OCMCS nanoparticles by Caco-2 cells was confirmed via confocal laser scanning microscope (CLSM). In vivo toxicity assays were performed via histopathological evaluation, and no specific anatomical pathological changes or tissue damage was observed in the tissues of carps. The extent of tissue distribution and retention following oral administration of FITC-OCMCS nanoparticles was analyzed for 3 days. After 3 days, the nanoparticles remained detectable in the muscle, heart, kidney, liver, intestine, and spleen. The results showed that 34.32% of the particles were localized in the liver, 18.79% in the kidney, and 17.36% in the heart. The lowest percentage was observed in the muscle. These results implied that OCMCS nanoparticles had great potential to be applied as safe carriers for the oral administration of protein drugs.

摘要

油酰羧甲基壳聚糖(OCMCS)可在中性 pH 下溶解。其在去离子水中的临界胶束浓度(CMC)为 0.021mg/ml。通过自组装成功制备了平均直径为 215.34nm、Zeta 电位为 19.26mV、呈近球形的 OCMCS 纳米粒子,这可通过电子显微镜确定。OCMCS 纳米粒子对红细胞膜的破坏作用较小。MTT 存活试验表明,其对 Caco-2 细胞和 MEFs 细胞无明显细胞毒性。通过共聚焦激光扫描显微镜(CLSM)证实了 FITC 标记的 OCMCS 纳米粒子被 Caco-2 细胞摄取。通过组织病理学评估进行体内毒性试验,在鲤鱼组织中未观察到特定的解剖病理变化或组织损伤。分析了口服 FITC-OCMCS 纳米粒子 3 天后的组织分布和保留程度。3 天后,纳米粒子仍可在肌肉、心脏、肾脏、肝脏、肠和脾脏中检测到。结果表明,34.32%的粒子定位于肝脏,18.79%定位于肾脏,17.36%定位于心脏。在肌肉中观察到的比例最低。这些结果表明,OCMCS 纳米粒子有很大的潜力作为口服给药蛋白质药物的安全载体。

相似文献

1
Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers.聚合物两亲性纳米粒作为口服药物载体的生物相容性、细胞摄取和体内分布。
Colloids Surf B Biointerfaces. 2013 Mar 1;103:345-53. doi: 10.1016/j.colsurfb.2012.11.012. Epub 2012 Nov 29.
2
In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles.体外评价聚合物两亲性纳米粒的黏膜黏附性和渗透增强作用。
Carbohydr Polym. 2012 Jun 20;89(2):453-60. doi: 10.1016/j.carbpol.2012.03.028. Epub 2012 Mar 19.
3
Preparation and evaluation of oleoyl-carboxymethy-chitosan (OCMCS) nanoparticles as oral protein carriers.制备和评价油酰羧甲基壳聚糖(OCMCS)纳米粒作为口服蛋白质载体。
J Mater Sci Mater Med. 2012 Feb;23(2):375-84. doi: 10.1007/s10856-011-4470-9. Epub 2011 Dec 3.
4
Polymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxel.基于壳寡糖的聚合物纳米粒作为阿维 A 酸和紫杉醇共载药载体。
Carbohydr Polym. 2015 Sep 20;129:25-34. doi: 10.1016/j.carbpol.2015.04.036. Epub 2015 Apr 27.
5
Self-assembled nanoparticles based on amphiphilic chitosan derivative and hyaluronic acid for gene delivery.基于两亲性壳聚糖衍生物和透明质酸的自组装纳米粒用于基因递送。
Carbohydr Polym. 2013 Apr 15;94(1):309-16. doi: 10.1016/j.carbpol.2012.12.058. Epub 2013 Jan 5.
6
Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.甘草酸修饰的 O-羧甲基壳聚糖纳米粒作为靶向肝癌的药物载体。
Biomaterials. 2012 Oct;33(30):7594-604. doi: 10.1016/j.biomaterials.2012.06.072. Epub 2012 Jul 13.
7
Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.制备并评价了经甘草酸表面修饰的 N-己酰化壳聚糖纳米粒用于肝细胞靶向。
Drug Dev Ind Pharm. 2009 Nov;35(11):1348-55. doi: 10.3109/03639040902939197.
8
Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?壳聚糖-巯基乙酸共轭物:口服非病毒基因递送的替代载体?
J Biomed Mater Res A. 2007 Jul;82(1):1-9. doi: 10.1002/jbm.a.31135.
9
Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.新型载蛋白硫酸软骨素-壳聚糖纳米粒的制备与表征。
Acta Biomater. 2011 Oct;7(10):3804-12. doi: 10.1016/j.actbio.2011.06.026. Epub 2011 Jun 24.
10
Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.基于疏水改性壳聚糖的自组装纳米颗粒作为阿霉素载体
Nanomedicine. 2007 Dec;3(4):258-65. doi: 10.1016/j.nano.2007.08.002. Epub 2007 Oct 24.

引用本文的文献

1
Polymeric Nanoparticles for Delivery of Natural Bioactive Agents: Recent Advances and Challenges.用于递送天然生物活性剂的聚合物纳米颗粒:最新进展与挑战
Polymers (Basel). 2023 Feb 23;15(5):1123. doi: 10.3390/polym15051123.
2
Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far.用于药物递送的聚合物纳米生物材料的风险评估:到目前为止我们能从文献中学到什么。
Front Bioeng Biotechnol. 2019 Oct 23;7:261. doi: 10.3389/fbioe.2019.00261. eCollection 2019.
3
Co-delivery of free vancomycin and transcription factor decoy-nanostructured lipid carriers can enhance inhibition of methicillin resistant Staphylococcus aureus (MRSA).
载游离万古霉素和转录因子诱饵纳米结构脂质载体的共递送可以增强对耐甲氧西林金黄色葡萄球菌(MRSA)的抑制作用。
PLoS One. 2019 Sep 3;14(9):e0220684. doi: 10.1371/journal.pone.0220684. eCollection 2019.
4
Biocompatibility Profile and In Vitro Cellular Uptake of Self-assembled Alginate Nanoparticles.自组装海藻酸钠纳米颗粒的生物相容性特征和体外细胞摄取。
Molecules. 2019 Feb 3;24(3):555. doi: 10.3390/molecules24030555.
5
Self-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin delivery.基于两亲性壳聚糖衍生物和精氨酸的自组装纳米颗粒用于口服姜黄素递送。
Int J Nanomedicine. 2016 Sep 6;11:4397-4412. doi: 10.2147/IJN.S106116. eCollection 2016.
6
Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer.载青蒿琥酯的壳聚糖包衣脂质纳米囊作为抗乳腺癌潜在药物递送系统的研发与评价
AAPS PharmSciTech. 2015 Dec;16(6):1307-16. doi: 10.1208/s12249-015-0311-3. Epub 2015 Mar 19.
7
Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.蛋白质和肽类药物递送的最新进展:特别关注聚合物纳米颗粒
Protein Pept Lett. 2014;21(11):1102-20. doi: 10.2174/0929866521666140807114240.
8
Holistic assessment of covalently labeled core-shell polymeric nanoparticles with fluorescent contrast agents for theranostic applications.用于诊疗应用的、带有荧光造影剂的共价标记核壳聚合物纳米颗粒的整体评估。
Langmuir. 2014 Jan 21;30(2):631-41. doi: 10.1021/la403943w. Epub 2014 Jan 6.